In the future, we will use animal models and clinical trials to explore the role of USP48 in the occurrence and development of AML, and further evaluate the potential value of USP48 specific inhibitors in AML treatment with the PDX models. The gene discussed is USP48; the disease is acute myeloid leukemia.